^GSPC - S&P 500
| Previous Close | 2,670.14 |
| Open | 2,675.40 |
| Volume | 1,858,105,237 |
| Day's Range | 2,657.99 - 2,682.86 |
| 52 Week Range | 2,352.72 - 2,872.87 |
| Avg. Volume | 3,731,818,064 |
Yahoo Finance Video•30 minutes agoMarket recap for Monday, April 23rd
Market recap for Monday, April 23rd
- MarketWatch•8 minutes ago
Don’t blame oil prices for a widening gap in government bond yields, says BMO
Hysteria over a flattening yield curve saw a brief reprieve after a sharp selloff in long-dated government bonds sent the 10-year Treasury yield in striking distance of 3%, a key psychological level. See: Stock investors are freaking out about bonds ending a 3 decadelong bull run—but should they be? Market participants had blamed the swiftness of the bearish move on the oil prices(CLM18.NYM) nearing $70 a barrel which drove 10-year break-even rates, or inflation expectations, over the next decade, close to a more than three-year high of 2.19%, according to Tradeweb data.
- MarketWatch•15 minutes ago
The S&P 500 just logged its longest stretch in correction territory in nearly a decade
The S&P 500 just recorded a dubious milestone. The broad-market benchmark has put in its longest run in correction territory since May 1, 2008, according to WSJ Market Data Group. The S&P 500 index (^GSPC) has been in correction territory, defined as a decline of at least 10% from a recent peak, for 51 trading sessions, including Monday’s lackluster finish for the index.
- MarketWatch•25 minutes ago
Stock investors are freaking out about bonds ending a 3 decadelong bull run—but should they be?
Government bond yields climbing and a shrinking gap between short-term and long-term Treasury rates have prompted some consternation on Wall Street, driving equity prices lower as investors fret about what these dynamics mean for U.S. economic growth as it enters its ninth year of expansion. Fears about a so-called flattening yield curve have taken center stage, with investors fixated on the gap between the 2-year Treasury notes (XTUP:TMUBMUSD02Y=X) and the 10-year benchmark (XTUP:TMUBMUSD10Y=X), which last Tuesday touched the narrowest point—41 percentage points—in more than a decade. The yield curve is often tracked as a measure of sentiment about the economy’s overall health.
- Motley Fool•41 minutes ago
What Happened in the Stock Market Today
On a mixed day for the major benchmarks, Hasbro jumped after reporting weak results, and Alcoa fell on lower aluminum prices.
- Bloomberg•59 minutes ago
Follow-the-Leader Is Fast Becoming a Loser's Game in the Stock Market
Finding a leader to follow has rarely been this tough for stock investors.
- Barrons.com•59 minutes ago
The Biggest Movers: Henry Schein Shines; Arconic Slumps
Henry Schein (HSIC) outpaced all other S&P 500 components on Monday, on news that it will spin off the Animal Health business. Henry Schein gained $4.72, or 6.8%, to $73.79. The S&P 500 rose 0.15 points, ...
- Bloomberg•59 minutes ago
S&P 500 Winners and Losers for 04/23
These are today's winners and losers from the S&P 500. (Source: Bloomberg)
Reuters•1 hour agoWall St ends mixed as investors eye earnings
By Stephen Culp NEW YORK (Reuters) - Wall Street ended mixed on Monday as concerns about soft smartphone demand weighed on tech stocks and pulled the Nasdaq lower while earnings optimism protected against ...
Reuters•1 hour agoWall Street ends mixed as investors eye earnings
Wall Street ended mixed on Monday as concerns about soft smartphone demand weighed on tech stocks and pulled the Nasdaq lower while earnings optimism protected against deeper losses. Tech stocks dragged ...
- MarketWatch•1 hour ago
Dow extends losing skid as investors wrestle with rising bond yields
U.S. stocks end the session little changed on Monday as investors grappled with rising bond yields and a mixed bag of earnings reports.
- Reuters•1 hour ago
Amid drug price worries, earnings to test U.S. pharma, biotech shares
Major U.S. pharmaceutical and biotechnology companies, whose shares have been laggards even in a sluggish market, face a litmus test in the corporate earnings season as investors already gun-shy over concerns about pressures on drug prices prepare to give a sharp eye for both hits and misses. As a group, pharmaceutical stocks in the S&P 500 are down about 4 percent so far this year, while S&P biotech stocks are off about 6 percent. Shares of Biogen Inc, Celgene Corp and Bristol-Myers Squibb Co are all down at least 14 percent this year.
Reuters•1 hour agoGlobal stocks fall as U.S. yields rise, commodities tumble
A gauge of global equity markets declined on Monday as U.S. bond yields moved closer to the 3 percent level that has unsettled investors in recent months, while a fall in commodity prices pressured materials stocks. U.S. bond prices fell, with the 10-year yield hitting its highest in over four years at 2.998 percent. Investors are worrying about the growing supply of government debt and accelerating inflation as oil and commodity prices have been rising in recent weeks.
- Associated Press•2 hours ago
How major US stock indexes fared Monday
U.S. stocks couldn't hang on to an early gain and finished mostly lower Monday as technology companies slipped. Bond prices continue to fall and the yield on the 10-year Treasury note drew closer to 3 ...
Associated Press•2 hours agoUS stocks wobble and bond yields set four-year highs
Investors once again focused on corporate deals Monday as utility company Vectren agreed to be bought by CenterPoint Energy for $6 billion, while the CEO of Sears called for the company to sell more assets and health care products company Henry Schein said it will split off its animal health unit. Aluminum producers tumbled after the Treasury Department moved to ease sanctions against Russian aluminum company Rusal. Bond yields have climbed this year as investors are starting to see signs that inflation is picking up and the Federal Reserve continues to raise interest rates.
Reuters•2 hours agoStocks fall as U.S. yields rise, commodities tumble
A gauge of global equity markets declined on Monday as U.S. bond yields moved closer to the 3 percent level that has unsettled investors in recent months, while a fall in commodity prices pressured materials ...
- MarketWatch•2 hours ago
Alphabet stock rises after earnings beat
Alphabet Inc. shares rose 2.5% in the extended session Monday after the company topped analyst estimates. Alphabet stock was down a fraction to $1,073.44 during the regular session. The company reported ...
- MarketWatch•2 hours ago
Dow marks longest losing skid in 7 weeks as government bond yields hover near 3%
The Dow Jones Industrial Average on Monday finished in negative territory for a fourth straight session, marking its longest losing trend since early March, as Wall Street wrestled with rising government ...
- Reuters•2 hours ago
US STOCKS SNAPSHOT-Wall St flat as tech stocks, bond yields offset earnings
Wall Street struggled for direction on Monday, ending the session largely unchanged, as signs of waning smartphone demand weighed on the Nasdaq and as rising bond yields offset earnings optimism. The Dow ...
- CNBC•2 hours ago
CNBC Transcript: CNBC Exclusive: Hewlett-Packard Chairman & CEO Meg Whitman Speaks with CNBC’s “Squawk on the Street” Today
CNBC Exclusive: CNBC Transcript: DoubleLine Capital CEO Jeffrey Gundlach Speaks with CNBC’s Scott Wapner Today
- MarketWatch•3 hours ago
Ford earnings offer another chance for the stock to shake off its slump
Ford Motor Co. is slated to report first-quarter earnings on Wednesday, with markets hoping the auto maker will show more progress toward much-touted cost-cutting measures.
- CNBC Videos•2 hours ago
Dow closes lower for fourth straight session
Discussing the winners and losers of the market at the closing bell with Michael Yoshikami, Destination Wealth Management; Jim Cahn, Wealth Enhancement Group; and Tony Crescenzi, Pimco.
- CNBC Videos•2 hours ago
Dow down 134 points at its low
CNBC's Bob Pisani looks at the day's market action.
